Endocrine

Cutaneous neuroendocrine carcinoma

ORPHA:79140 ↗

Search all Cutaneous neuroendocrine carcinoma trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

241

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

17 Jul 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2NCT05136196

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Sponsor National Cancer Institute (NCI)Where United States (229 sites)Studying Biopsy Procedure, Biospecimen CollectionUpdated 4 Sept 2026

See details

RecruitingPhase 2NCT02479698

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Sponsor M.D. Anderson Cancer CenterWhere United States (1 site)Studying Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker AnalysisUpdated 4 Sept 2026

See details

RecruitingNCT02471352

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Sponsor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Where United States (1 site)Updated 2 Sept 2026

See details

RecruitingPhase 1 / Phase 2NCT07070232

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Sponsor BioNTech SEWhere United States, Australia, Belgium +6 (76 sites)Studying BNT326, PumitamigUpdated 2 Sept 2026

See details

RecruitingPhase 1 / Phase 2NCT05896839

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Sponsor National Cancer Institute (NCI)Where United States (26 sites)Studying Biopsy Procedure, Biospecimen CollectionUpdated 31 Aug 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 54 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Australia Belgium China Germany Italy Spain Turkey (Türkiye)United Kingdom United States

Keep watching

Get an email when a new Cutaneous neuroendocrine carcinoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:79140 ↗

About Cutaneous neuroendocrine carcinoma

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).